Mode
Text Size
Log in / Sign up

Lower urinary tract symptoms

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for lower urinary tract symptoms

22 trials tracked for lower urinary tract symptoms: 8 in phase 3 or 4 and 3 with published results. The most-cited published study has 67 citations.

22Trials tracked
8Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 3 Phase 3 5 Phase 2 6 Other / NA 8
  1. Phase 3 Combined Behavioral and Drug Treatment of Overactive Bladder in Men Completed · 67 cited
  2. Phase 3 Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery Completed · 29 cited
  3. Phase 4 Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms Completed · 26 cited
  4. Phase 4 Deprescribing Tamsulosin in Older Men Completed
  5. Phase 4 A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters Completed
  6. Phase 3 An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms Completed
Show 16 more trials
  1. Phase 3 Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms Completed
  2. Phase 3 Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms Completed
  3. Phase 2 An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms Completed
  4. Phase 2 Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB Completed
  5. Phase 2 Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction Completed
  6. Phase 2 Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery Completed
  7. Phase 2 Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB Completed
  8. Phase 2 A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO) Completed
  9. N/A Bipolar Plasmakinetic TURP Vs Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms Completed
  10. N/A Embosphere® PROstate Post Market Study Completed
  11. N/A Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder Completed
  12. N/A Portable Pves Study Completed
  13. N/A Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) Completed
  14. N/A Uro-NIRS Clinical Study Completed
  15. N/A The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects Completed
  16. N/A Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction Completed

Showing the 22 most-cited and recently-updated of 22 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.